Measures of Obesity and Co-Morbid Conditions in Maori
|Study Design:||Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
|Study Start Date:||January 2003|
|Estimated Study Completion Date:||December 2005|
This is a body composition analysis study of people self-identifying Maori and non-Maori participants from both Dunedin and Invercargill. The study consists of a clinical visit for anthropometry and oral glucose tolerance test (OGTT), followed by a single Dexa Scan visit. Participants meeting all the inclusion criteria were invited to participate in the study.
Outcome will be determined by examining Dexa Scan data and surrogate clinical endpoints. The clinical endpoints include: anthropometric measurements, Dexa analysis, bioelectric impedance, and BP measurements, and the biochemical measures of: lipid profile, fasting insulin and glucose, liver functions and uric acid levels.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00208598
|Edgar National Centre for Diabetes Research|
|Dunedin, Otago, New Zealand, 9001|
|Study Director:||Jim I Mann, FRACP, PhD||Edgar National Centre for Diabetes Research|